Events
Email Page
Celesq® CLE Program: FDA in the Year of COVID – How FDA Tackled the Pandemic and What to Expect from FDA in 2021
February 11, 2021

On February 11, Axinn partner Chad Landmon and associates Alex Alfano and Michelle Divelbiss presented a Celesq® CLE program entitled, "FDA in the Year of COVID – How FDA Tackled the Pandemic and What to Expect from FDA in 2021." This program looked forward to 2021, and discussed whether FDA’s operations will go back to their pre-pandemic normal and how FDA might continue to use real world evidence to support important regulatory decisions.

Click here for more information.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.